01—Abstract
Summary
Summary of the 8-K filed September 24, 2026. Cited figures are marked; the original filing is the authoritative source.
This Form 8-K contains no financial results, operating updates, or material transaction disclosure.
Its only substantive content is Item 9.01 (Financial Statements and Exhibits), which lists three exhibits: a legal opinion of counsel (Exhibit 5.01, from Karen Wang, Esq.), a schedule of Citigroup securities registered under Section 12(b) as of the filing date (Exhibit 99.01), and the Inline XBRL cover page (Exhibit 104). Exhibit 5.01 is typically filed alongside a registration statement, so this filing most likely supports a securities registration or offering rather than reporting a corporate event. The filing itself does not state the purpose, size, or terms of any offering, so the opinion's contents should be reviewed directly.
Exhibit 99.01 lists Citigroup's exchange-listed securities on the New York Stock Exchange: common stock (ticker C), the 6.250%a Noncumulative Preferred Stock, Series II depositary shares (C PR R), two trust preferred securities series (C/36Y and C N), and several Series N floating rate medium-term notes issued by Citigroup Global Markets Holdings Inc. (CGMHI) and guaranteed by Citigroup. The list includes notes maturing in April 2028, September 2028, October 2028, and March 2029, plus a September 17, 2026 note. Because that maturity date precedes the September 24, 2026 filing date, that entry may be a carryover from an earlier schedule and should be checked against current outstanding debt.
For investors, this filing is administrative. It does not change Citigroup's capital position, earnings outlook, or risk profile. Its value lies in confirming the current listing status of Citigroup's exchange-traded equity, preferred, trust preferred, and note instruments, and in signaling that the company is updating its securities registration documents.
02—Key points
Key Highlights
- Form 8-K filed September 24, 2026 contains no earnings, financial results, or material operating disclosures; the only Item reported is 9.01 (Financial Statements and Exhibits).
- Exhibit 5.01 is a legal opinion from Karen Wang, Esq., which is usually filed with a registration statement, suggesting new or updated securities offerings.
- Exhibit 99.01 confirms NYSE listing of Citigroup common stock (ticker C) and the 6.250% Noncumulative Preferred Stock, Series II depositary shares (C PR R).
- Trust preferred securities listed include the 7.625% TruPS of Citigroup Capital III (C/36Y) and the 7.875% Fixed/Floating Rate TruPS of Citigroup Capital XIII (C N), each with Citigroup's guaranty.
- Several Series N floating rate medium-term notes issued by CGMHI are listed with maturities in 2028 and 2029 (C/28, C/28A, C/28B, C/29A), each guaranteed by Citigroup.
- A September 17, 2026 floating rate MTN (C/26) appears in the schedule even though it matures before the filing date, so the list may not be fully current.
- The filing includes an Inline XBRL cover page (Exhibit 104), consistent with standard SEC electronic reporting requirements.
03—Questions
Frequently Asked Questions
Does this 8-K report Citigroup's financial results or any material business event?
No. The filing reports only Item 9.01 (Financial Statements and Exhibits). It contains no earnings, balance sheet data, acquisitions, dispositions, or management changes.
Why would Citigroup file an opinion of counsel in an 8-K?
Exhibit 5.01 is a legal opinion on the validity of securities. Companies file these in connection with registration statements, so this likely supports a new or amended offering. The specific securities covered are not identified in the filing excerpt.
Which Citigroup securities trade on the NYSE according to this filing?
Exhibit 99.01 lists common stock (C), 6.250% Noncumulative Preferred Stock, Series II depositary shares (C PR R), Citigroup Capital III 7.625% TruPS (C/36Y), Citigroup Capital XIII 7.875% FXD/FRN TruPS (C N), and several CGMHI Series N floating rate medium-term notes (C/28, C/28A, C/28B, C/29A, and C/26).
Does the September 2026 note listing affect investors?
The schedule includes a floating rate MTN due September 17, 2026, which matured before the September 24, 2026 filing date. Investors should confirm its status with the company, since the listing may be stale and does not necessarily reflect outstanding obligations.
Does this filing change Citigroup's financial outlook or risk profile?
No material change is disclosed. The filing is administrative and does not provide information about capital, liquidity, earnings, or risk. Investors should consult Citigroup's periodic reports (10-Q and 10-K) and any prospectus supplements for those details.
04—Continue